Solid Biosciences Inc. — Director's Dealing 2020

Feb 12, 2020

SEC Form 4/A — Form 4/A

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2020-01-27

Reporting Person: Ganot Ilan (Director, CEO & President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-27	Employee Stock Option (Right to Buy)	$3.47	A	4320	Acquired	2030-01-27	Common Stock (4320)	Indirect

Footnotes

F1: This amendment to the Form 4 filed on January 29, 2020 (the "Original Form 4") is being filed to add a transaction inadvertently omitted from the Original Form 4. The Original Form 4 omitted an option grant to the reporting person's wife.

F2: This option was granted on January 27, 2020 and vests in four equal annual installments on the anniversary of the grant date.